Coherent Corp.
COHR
$258.16
+4.18%
Coherent Corp. is a vertically integrated manufacturer of lasers, optical devices, and engineered materials for communications and industrial markets. It is a key player in photonics and optoelectronics, leveraging its integrated manufacturing to serve critical technology infrastructure.…
COHR
Coherent Corp.
$258.16
Related headlines
Investment Opinion: Should I buy COHR Today?
Based on a synthesis of the explosive growth narrative, strong analyst conviction, and concerning valuation and profitability metrics, the objective assessment is a Hold. The stock is not a clear 'Buy' at current levels due to its extreme valuation, which demands perfect execution of the AI growth story. Conversely, the powerful momentum and strategic positioning prevent a 'Sell' rating. Investors should wait for a more attractive entry point or clearer evidence of sustained profitability and free cash flow generation before establishing new positions.
Sign up to view all
COHR 12-Month Price Forecast
The long-term growth narrative is compelling, but the short-to-medium-term risk/reward is balanced at the current price. The stock needs to grow into its valuation, making future price action highly dependent on quarterly execution against high expectations.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Coherent Corp.'s 12-month outlook, with a consensus price target around $335.61 and implied upside of +30.0% versus the current price.
Average Target
$335.61
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$207 - $336
Analyst target range
Wall Street analyst coverage is active, with eight firms providing estimates. The consensus points to strong future growth, with an average EPS estimate of $9.47 and average revenue estimate of $10.35 billion. Recent institutional ratings are uniformly positive, with actions from firms like Rosenblatt, Stifel, Needham, Barclays, and JP Morgan all being 'Buy' or 'Overweight', indicating strong analyst conviction.
Bulls vs Bears: COHR Investment Factors
Coherent presents a high-risk, high-reward investment thesis centered on its strategic position in the AI infrastructure build-out, validated by its NVIDIA partnership. However, this optimism is fully reflected in a parabolic stock price and extreme valuation multiples, which hinge on flawless execution of future growth. The stock's fate is tightly coupled to the AI investment cycle and its ability to translate revenue growth into sustained profitability.
Bullish
- Strong AI Partnership & Growth: Strategic partnership with NVIDIA validates technology and opens massive AI infrastructure market.
- Robust Revenue Growth: Latest quarterly revenue grew 17.5% YoY, showing strong business momentum.
- Unanimous Analyst Conviction: All recent institutional ratings are Buy/Overweight, with high EPS growth estimates.
- Solid Financial Health: Strong current ratio of 2.19 and manageable debt-to-equity of 0.48.
Bearish
- Extreme Valuation Multiples: Trailing P/E of 279.75 is extremely high, pricing in near-perfect execution.
- Inconsistent Profitability: Negative TTM free cash flow and volatile quarterly net income history.
- Poor Capital Efficiency: Low ROE (0.61%) and ROA (2.90%) indicate weak returns on capital.
- High Beta & Volatility: Beta of 1.9 implies ~90% more volatility than the market, increasing risk.
COHR Technical Analysis
The stock has exhibited extremely strong long-term momentum, rising 111.2% over the past six months and 266.8% over the past year, significantly outperforming the broader market. However, recent performance shows volatility, with a 1-month decline of 8.0% and a 3-month gain of 29.1%, indicating a potential consolidation phase after a parabolic advance. The current price of $238.21 sits near the upper end of its 52-week range of $45.58 to $300.20, representing a pullback from recent highs but still reflecting substantial investor optimism.
Beta
1.91
1.91x market volatility
Max Drawdown
-35.5%
Largest decline past year
52-Week Range
$46-$300
Price range past year
Annual Return
+282.2%
Cumulative gain past year
| Period | COHR Return | S&P 500 |
|---|---|---|
| 1m | -8.1% | -3.6% |
| 3m | +32.8% | -4.0% |
| 6m | +127.3% | -2.0% |
| 1y | +282.2% | +16.2% |
| ytd | +32.8% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COHR Fundamental Analysis
Revenue growth has been positive, with the latest quarterly revenue of $1.686 billion showing a 17.5% year-over-year increase. Profitability is improving but remains inconsistent; the latest quarter reported net income of $147 million (net margin of 8.7%), a recovery from prior quarters of losses, though the trailing twelve-month free cash flow is negative at -$103.6 million. Financial health appears stable with a debt-to-equity ratio of 0.48 and a strong current ratio of 2.19, but operational efficiency metrics like ROE (0.61%) and ROA (2.90%) are currently low, indicating room for improvement in capital allocation.
Quarterly Revenue
$1.7B
2025-12
Revenue YoY Growth
+0.17%
YoY Comparison
Gross Margin
+0.36%
Latest Quarter
Free Cash Flow
$-103617000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COHR Overvalued?
Given the company's positive net income in the latest quarter, the primary valuation metric is the P/E ratio. The trailing P/E is extremely high at 279.75, reflecting the stock's massive price appreciation and past earnings volatility. The forward P/E of 32.09, based on analyst estimates, suggests expectations for significant earnings growth. Peer comparison data is not available in the provided inputs.
PE
279.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -173x~520x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.2x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is valuation. The stock's 266% one-year surge and trailing P/E of 279.75 leave no margin for error. Any disappointment in revenue growth, margin expansion, or integration of the NVIDIA partnership could trigger a severe multiple contraction. Operational risks include inconsistent profitability, as seen in quarterly results swinging from losses to profits, and negative TTM free cash flow of -$103.6 million, which raises questions about self-sustainability. Market risks are elevated due to the stock's high beta (1.9), making it highly sensitive to broader market downturns, rising rates, or a slowdown in AI-related capital expenditure. Geopolitical and macroeconomic risks, highlighted in recent news regarding oil prices and stagflation fears, could disproportionately impact this growth-oriented, high-multiple stock.
FAQ
The key risks are valuation compression, execution risk, and market volatility. Any failure to meet high growth expectations could cause a sharp decline from its elevated P/E multiple. The company's history of inconsistent quarterly profits and negative TTM free cash flow (-$103.6M) highlights execution risk. Finally, with a beta of 1.9, the stock is likely to fall more than the market during downturns and is sensitive to macroeconomic shifts impacting tech spending.
The 12-month outlook is highly bifurcated. The base case (50% probability) sees volatile trading in a range of $200-$280 as the company works to grow into its valuation. The bull case (25%) could see a retest of the $300+ highs on stellar execution, while the bear case (25%) risks a pullback towards $120-$180 if growth disappoints. The consensus hinges on the company delivering on analyst EPS estimates of approximately $9.47.
Based on traditional metrics, COHR appears significantly overvalued. Its trailing P/E of 279.75 is exceptionally high. However, the forward P/E of 32.09, based on analyst estimates for EPS of $9.47, reflects the market's expectation of massive earnings growth. The valuation is thus a bet on flawless future execution; it is rich on current results but potentially reasonable if the company hits its aggressive growth targets, leaving no room for error.
COHR is a high-conviction growth story but a questionable buy at current prices. While analyst sentiment is unanimously positive and the AI partnership with NVIDIA is a major catalyst, the stock's 266% one-year gain and extreme trailing P/E ratio of 279.75 suggest much of the future success is already priced in. A more attractive entry point may present itself if the stock consolidates or if the company demonstrates several quarters of sustained profit and positive free cash flow.
COHR is primarily suited for long-term investors with high risk tolerance who believe in the multi-year AI infrastructure thesis and can withstand significant volatility. The stock's high beta and valuation sensitivity make it a poor fit for short-term trading or risk-averse investors. A long-term horizon allows time for the company's fundamental growth to potentially justify its current price, but investors must be prepared for a rocky journey.